Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

Support for the N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis of schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an approach for treatment of this devastating disease. The ability of metabotropic glutamate (mGlu) receptors to modulate glutamat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Brain
Asıl Yazarlar: Maksymetz, James, Moran, Sean P., Conn, P. Jeffrey
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405554/
https://ncbi.nlm.nih.gov/pubmed/28446243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13041-017-0293-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller